Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Sionna Therapeutics, Inc. | 165,440 | reported | 02 Jan 2026 | tx 9+323,260−85,000 |
| Kymera Therapeutics, Inc. | 13,000 | reported | 11 May 2026 | tx 19+176,068−39,000 |
| ACADIA PHARMACEUTICALS INC | 10,553 | reported | 30 Apr 2021 | tx 26+256,705−104,655 |
| Kronos Bio, Inc. | 0 | reported | 20 Jun 2025 | tx 14+108,746−161,496 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 May 2026 | EXERCISE | Kymera Therapeutics, Inc. | 3,000 | 31.20 USD | 10b5-1 |
| 11 May 2026 | SALE | Kymera Therapeutics, Inc. | 3,000 | 87.00 USD | 10b5-1 |
| 11 May 2026 | EXERCISE | Kymera Therapeutics, Inc. | 3,000 | 0.00 USD | 10b5-1deriv |
| 02 Jan 2026 | GRANT_AWARD | Sionna Therapeutics, Inc. | 165,440 | 0.00 USD | deriv |
| 29 Aug 2025 | SALE | Sionna Therapeutics, Inc. | 748 | 25.18 USD | |
| 02 Sept 2025 | SALE | Sionna Therapeutics, Inc. | 8,836 | 25.08 USD | |
| 27 Aug 2025 | SALE | Sionna Therapeutics, Inc. | 3,618 | 25.10 USD | |
| 26 Aug 2025 | SALE | Sionna Therapeutics, Inc. | 3,700 | 25.13 USD | |
| 28 Aug 2025 | SALE | Sionna Therapeutics, Inc. | 16,098 | 25.97 USD | |
| 19 Aug 2025 | SALE | Sionna Therapeutics, Inc. | 34,500 | 21.08 USD | |
| 20 Aug 2025 | SALE | Sionna Therapeutics, Inc. | 17,500 | 22.69 USD | |
| 25 Jun 2025 | GRANT_AWARD | Kymera Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 20 Jun 2025 | TENDER | Kronos Bio, Inc. | 25,296 | 0.57 USD | |
| 20 Jun 2025 | OTHER | Kronos Bio, Inc. | 17,000 | 0.00 USD | deriv |
| 20 Jun 2025 | OTHER | Kronos Bio, Inc. | 34,000 | 0.00 USD | deriv |
| 20 Jun 2025 | OTHER | Kronos Bio, Inc. | 15,450 | 0.00 USD | deriv |
| 20 Jun 2025 | OTHER | Kronos Bio, Inc. | 26,871 | 0.00 USD | deriv |
| 20 Jun 2025 | OTHER | Kronos Bio, Inc. | 25,879 | 0.00 USD | deriv |
| 20 Jun 2025 | OTHER | Kronos Bio, Inc. | 17,000 | 0.00 USD | deriv |
| 11 Jun 2025 | SALE | Kymera Therapeutics, Inc. | 4,500 | 50.00 USD | |
| 11 Jun 2025 | EXERCISE | Kymera Therapeutics, Inc. | 4,500 | 20.29 USD | |
| 11 Jun 2025 | EXERCISE | Kymera Therapeutics, Inc. | 4,500 | 0.00 USD | deriv |
| 03 Jun 2025 | SALE | Kymera Therapeutics, Inc. | 4,800 | 47.00 USD | |
| 03 Jun 2025 | EXERCISE | Kymera Therapeutics, Inc. | 12,000 | 27.67 USD | |
| 03 Jun 2025 | SALE | Kymera Therapeutics, Inc. | 7,200 | 45.50 USD |